Re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024

著录项

• 来源
  《European urology》 |2021年第3期|E83-E84|共2页
• 作者

  de Bono Johann; Hussain Maha; Kang Jinyu;

  展开▼
• 作者单位

  Inst Canc Res, Downs Rd, Sutton SM2 5PT, Surrey, England;

  Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA;

  AstraZeneca, Global Med Dev, Oncol, Gaithersburg, MD USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 英语
• 中图分类 泌尿科学（泌尿生殖系疾病）;
• 关键词